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MiceThe gut transit of T4 phages was studied in axenic mice mono-colonized with the non-pathogenic Escherichia
coli strain K-12. Thirty minutes, 1 and 2 h after phage feeding, T4 phage had reached the jejunum, ileum and
cecum, respectively. Phage was found in the lumen and was also associated with the mucosa. One day later
no phage was detected in the feces. Compared to germ-free control animals, oral T4 phage led to a 300-fold
higher fecal phage titer in mice mono-colonized with E. coli strain WG-5. The in vivo T4 phage replication
was transient and reached peak fecal titers about 8 h after oral phage application followed by a rapid titer
decrease over two days. Similar data were obtained in mice colonized with E. coli strain Nissle. In contrast,
orally applied T7 phage experienced a massive and sustained in vivo replication in mice mono-colonized
with E. coli strain WG-5 irrespective whether phage or E. coli host was applied ﬁrst. T7 phage replication
occurred mainly in the large intestine. High titers of T7 phage and high E. coli cell counts coexisted in the
feces. The observation of only 20% T7 phage-resistant fecal E. coli colonies suggests a refuge model where
phage-sensitive E. coli cells are physically or physiologically protected from phage infection in the gut. The
difference between T7 and T4 with respect to gut replication might partly reﬂect their distinct in vitro
capacity to replicate on slowly growing cells.
© 2009 Elsevier Inc. All rights reserved.Introduction
Antibiotic-resistant bacteria have become such a serious problem
in current medical practice (Furuya and Lowy, 2006) that govern-
mental health agencies have issued research calls for alternative
treatment options against bacterial infections (http://www.cihr-irsc.
gc.ca/e/31302.html). From a conceptual point of view, one of the most
promising alternative approaches is phage therapy (Brüssow, 2005;
Merril et al., 2003). In fact, phage preparations against diarrheal
diseases and wound infections can be bought as registered over-the-
counter medicine in Russian pharmacies. However, neither the
microbiological characteristics of these phage preparations nor the
clinical studies conducted with them were described in detailed
recent scientiﬁc publications (Sulakvelidze et al., 2001). Consequent-
ly, the treatment and prevention claims made for these phage
preparations were regarded with substantial skepticism in the
Western world, despite the fact that British and US veterinarians
demonstrated the efﬁcacy of oral phage against Escherichia coli
diarrhea in calves (Smith and Huggins, 1983; Smith et al., 1987a,b)
and respiratory E. coli infections in chicken (Huff et al., 2002).
E. coli bacteriophage T4, a Myovirus, and T7, a Podovirus, are
prototypes of professional “virulent” (i.e. lytic) phages, whose
genomes are devoid of bacterial pathogenicity factors (Denou et al.,. Brüssow).
l rights reserved.2009; Kwon et al., 2008; Miller et al., 2003; Zuber et al., 2007). These
phages are thus good candidates for phage therapy approaches
against E. coli diarrhea in contrast to lambdoid coliphages, a temperate
Siphovirus, which frequently carry bacterial virulence genes (Brüssow
et al., 2004).
Phage T4 and its host E. coli belong to the best-characterized
interacting biological systems (Karam, 1994). Despite decades of
research in many laboratories, the phage infection process has with
few exceptions (Chibani-Chennouﬁ et al., 2004b; Tanji et al., 2005;
Weld et al., 2004) been studied with in vitro systems. Within the
framework of the reductionist approach, researchers had no incentive
to analyze the phage–bacterium interaction within the natural niche
of E. coli, i.e. the colon of warm blooded animals. In addition to the
complexity of the system, E. coli represents only a tiny fraction of the
gut ﬂora in mammals making the in vivo study of T4 phage–E. coli
interactions technically demanding. Small laboratory animals like
mice cannot be infected symptomatically with enteropathogenic E.
coli (Mundy et al., 2006; Savkovic et al., 2005) excluding this option to
increase the gut titer of E. coli. A colitis model using Citrobacter
infection in mice (Borenshtein et al., 2008) or enterohemorrhagic E.
coli strain O157:H7 in rabbits (Ritchie et al., 2003) are the nearest
surrogates. To study phage–E. coli interaction in a mammal, we used
germ-free mice that were mono-colonized with E. coli and which
received T4 or T7 phage orally. We used for these experiments E. coli
strains K-12, WG-5 or Nissle. K-12 was isolated from the stool of a
human subject (Lederberg, 2004) and became the prototype
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and virulence genes. WG5 is frequently used by phage ecologists as an
indicator strain (Guzman et al., 2008) because it has a wider
susceptibility to coliphages than K-12. E. coli strain Nissle was isolated
from a healthy human subject (Nissle, 1918). Due to its good gut
colonization properties it became a well-known probiotic E. coli strain
(Kruis et al., 2004). We observed that the in vivo properties of E. coli
phages T4 and T7 can only to a limited extent be predicted from their in
vitro growth properties. These gaps in the understanding of bacterial
host–phage interaction within the mammalian gut will not only limit
the rational design of phage therapy approaches, but remind us about
the gaps in our knowledge evenwith classical biologicalmodel systems.
Results
Bioavailability of oral T4 phage in the gut of mice mono-colonized
with E. coli strain K-12
In germ-free mice, which were mono-colonized with the E. coli
strain K-12, the highest bacterial titers were found in the cecum and
colon. Intermediate titers were seen in the stomach, while only low
titers were observed in the small intestine (Fig. 1A). All colonies,
which we recovered from the feces of these animals were in vitro
susceptible to a wide range of T4 phages.Fig. 1. Colonization of germ-free mice with commensal E. coli K12 (A) and Nissle (B,
with and without oral T4 phage). A. Intestinal bacterial counts in 2 germ-free mice
(displayed individually with black or grey bars) colonized with E. coli strain K12. The
abscissa indicates the gut segment (1: extract and 2: scraping of stomach; 3: wash and
4: scraping of duodenum; 5, 6 and 7, 8 wash and scraping of proximal and distal
jejunum, respectively; 9, 10 and 11, 12 and 13, 14 wash and scraping of proximal,
medial and distal ileum, respectively; 15: extract of cecum; 16, 17 and 18, 19 extract
and scraping of proximal and distal colon, respectively). B. Intestinal bacterial counts
(median) of 5 germ-free mice colonized with E. coli strain Nissle without (black bars) or
with T4-like phage treatment (grey bars). Mice were dissected 4 h after phage
inoculation. The bottom line indicates the anatomical location of the segments.Themicewere then force-fedwith 5×104 pfu of T4 phages RB49 and
RB69, representing two distinct subtypes of T4 coliphages (Comeau et
al., 2007; Desplats et al., 2002; Nolan et al., 2006). Groups of three mice
were dissected in a time sequence to follow the transit of the phage
through the gut as a function of time. Thirty minutes after oral phage
application, themajority of thephagewas locatedbetween theproximal
jejunum and the proximal ileum. Phagewas detected both in the lumen
and in the mucosal scrapings (Fig. 2A). Thirty minutes later, the phage
detection zone had shifted from the jejunum into the ileum, but phage
had not yet reached the cecum (Fig. 2B). Two hours after phage feeding,
the phage was found spread over the intestine and for the ﬁrst time it
was detected in the cecum and upper colon (Fig. 2C). Four hours after
inoculation, the phage had advanced into the large intestine, while the
small intestine now lackedphage (Fig. 2D).Mice are coprophageous (i.e.
they eat their fecal material): the reappearance of phage in the stomach
(Figs. 2C, D) therefore probably represents re-exposure to fecal phage
from ingested stool pellets. One day after oral phage application, no fecal
phage titer was measured.
No signiﬁcant phage ampliﬁcation (deﬁned as N10-fold titer
increase over oral phage) was seen in any gut segment when phage
concentrations or absolute phage titers accounting for the volumes of
intestinal ﬂuids were measured (data not shown). In addition, no
signiﬁcant decrease of intestinal E. coli titers was observed during the
4 h observation period (data not shown). It is premature to conclude
that no phage replication has occurred in vivo. It remains possible that
new phage was produced while oral phage was lost to inactivation in
the gut by stomach acidity, bile acids or digestive enzymes.
Oral T4 phage in the gut of mice mono-colonized with E. coli strain
WG-5 or Nissle
To control for loss of oral phage during gastrointestinal passage,
we followed the fecal excretion pattern of 107 pfu of phage T4 given
by intragastric application to six germ-free mice. Since no bacterial
cells were present in the gut of these animals, the fecal recovery
represents the passive transit of phage through the gut. Peak fecal
titers of 6×105 pfu/g feces were observed 6 h after phage application.
Two days after application, fecal phage was not any longer detected
(200 pfu/g was the sensitivity of our test for fecal samples, 50 pfu/ml
for secretions of small intestine) (Fig. 3).
In the following experiment, ﬁve mice were ﬁrst colonized with E.
coli strain WG-5. When mice had achieved a stable fecal excretion
level of 109 cfu/g feces indicating successful colonization, they
received the same amount of T4 phage as in the previous experiment.
Under these conditions, we observed a peak fecal phage titer of
108 pfu/g feces 8 h after phage application, indicating an about 300-
fold titer increase over the peak phage titer in germ-free animals.
However, this elevated phage titer was not maintained in the WG-5-
colonized mice: it dropped below 105 pfu/g at 20 h after phage
application (Fig. 3). In the T4-fed mice the fecal WG-5 titers remained
stable at 3×109 cfu/g (data not shown).
Very similar results were obtained with E. coli strain Nissle, which
achieved an approximately 10-fold higher intestinal colonization level
in mice than the K-12 strain. The Nissle strain was mainly found in the
large intestine and the stomach, while the titers in the small intestine
were low (compare Fig. 1B with Fig. 1A). The Nissle strain was resistant
to most phages from our T4 collection except T4-like phage isolate ED6.
By intragastric application, T4 phage ED6 was ﬁrst given to germ-free
mice at a dose of 106 pfu. As these mice lacked intestinal bacteria, we
observed again the passive transit of phage through the gut. Fecal phage
titers reached peak titers at 6 to 12h after oral application, subsequently
phages dropped to low titers at 24 h (Fig. 4) and were not detected any
longer 48 h after feeding (data not shown).When 106 pfu of phage ED6
was given to mice, which were already mono-colonized with strain
Nissle, about 50-fold higher fecal phage titers were observed (Fig. 4)
suggesting in vivophage replication. Despite the presence of target cells,
Fig. 2. Kinetics of the gastrointestinal phage T4 transit. 5×104 pfu of T4 phages RB69 and RB49 were applied to twelve mice, which were mono-colonized with E. coli strain K-12. The
ﬁgure shows the phage titer expressed as log pfu/g in the speciﬁed gut segment (see Fig. 1 for location) of mice dissected after 30 min (A), 60 min (B), 120 min (C), and 240min (D).
The ﬁgure shows the titer of T4 phage from 3 mice shown as black, grey and white bars.
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application, fecal phage titers dropped below the detection limit (data
not shown). Phage-treated mice did not differ from control mice for
fecal E. coli titers over a two-week follow-up period (data not shown).
To explore the effect of a larger oral phage dose on fecal E. coli
titers, we exposed Nissle-colonized mice to 108 pfu of phage ED6 by
intragastric inoculation. Five hours after phage application, phage-
treated mice showed decreased E. coli titers in the stomach and theFig. 3. Intestinal replication of phage T4. The fecal excretion pattern of 107 pfu phage T4
applied by gastric feeding to six germ-free mice lacking bacteria in their gut (ﬁlled
diamonds) and ﬁve mice mono-colonized with E. coli strain WG-5 (open diamonds).
The fecal pfu titer (ordinate) was plotted against recovery time of the feces in hours
(abscissa) after phage application.proximal small intestine, while in the large intestine phage-treated
and control mice showed similar E. coli titers (Fig. 1B).
Search for factors that potentially limit in vivo T4 phage infection
In conventional mice we observed clusters of bacterial cells
within the mucus overlaying the colonic epithelia (Figs. 5A, B) while
only isolated bacterial cells were seen in Nissle-colonized mice (Fig.Fig. 4. Intestinal replication of T4-like phage ED6. The fecal excretion pattern of phage
ED6 after gastric application of 106 pfu of phage to 5 germ-free mice lacking bacteria in
their gut (ﬁlled squares) and ﬁve mice mono-colonized with E. coli strain Nissle (open
diamonds). pfu (ordinate) are plotted against recovery time of the feces in hours
(abscissa) after phage application.
Fig. 5. Light and electron microscopy images of sections through the colon of mice. A. High magniﬁcation light microscopy through the mucus located on top of the colonic epithelial
cells. The dark violet staining particles in the mucus are bacteria (arrow). B, C. Thin section electron microscopy through the colon of a conventional control mouse (B) and a mouse
mono-colonized with E. coli strain Nissle in the absence of oral phage (C). Microvilli (mi) of the gut epithelium, followed by an empty gut lumen (l) and then a mucus sheet (mu) in
which microcolonies of bacteria (b) or a single E. coli cell (C, note the smooth cell wall) are indicated for an easier orientation. D. Section through a bacterial cell located in the colon
from a Nissle-mono-colonized mouse treated orally with phage T4 (note rough cell wall and membrane blob at 8 o'clock, arrow).
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microscopically in gut sections reﬂecting their lower gut colonization
level. Within the mucus embedding, the intestinal E. coli cells might
be physically shielded from phage infection. Alternatively, due to the
low gut bacterial titers the E. coli cells might be protected by
threshold phenomena. However, in phage-treated mice the colon-
associated Nissle cells showed a rough cell envelope and some cells
showed protruding membrane blobs (Fig. 5D), which were not
observed in control Nissle-colonized mice (Fig. 5C). It is unclear
whether these morphological changes are a consequence of phage
infection.
E. coli phage infections in the laboratory are normally conducted
with well aerated cells, while no oxygen is found in the lumen of thecolon. Therefore we tested whether the investigated T4 phages could
infect E. coli under anaerobic in vitro conditions. This was the case: our
T4 phages yielded in vitro similar titers under aerobic and anaerobic
growth (data not shown). No phage-resistant E. coli strains were
observed in mice exposed to T4 phage.
Massive intestinal replication of T7 coliphage in mice mono-colonized
with E. coli strain WG-5
Mice mono-colonized with the E. coli indicator cell WG5 received
then Podophage T7. In the ﬁrst experiment, 106 pfu T7 was given
intragastrically to germ-free mice. The T7 podophage was detected in
the feces 6 to 12 h after application and became undetectable
Fig. 6. Gut transit of T7 podophage in mice. A. 106 pfu of podophage T7 was applied to
the stomach of 5 germ-free mice and the fecal excretion pattern of the phage (in pfu/g,
ordinate) was followed over time (hours, abscissa). B. One week later 5 germ-free mice
were mono-colonized with E. coli strain WG-5. The ﬁgure shows the fecal excretion
pattern of 106 pfu podophage over time (hours after WG-5 cell addition).
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appearance, behavior or food intake after exposure to T7 phage.
One week later these mice were colonized with E. coli strain WG5.
Low amounts of this podophagemust have persisted in the mice since
we observed a rapid increase of the previously undetectable phage to
titers of up to 1010 pfu/g feces (Fig. 6B). Interestingly, these high fecal
phage titers coexisted with high fecal counts of E. coli strain WG5. We
measured between 5×108 and 3×109 cfu of WG5 per g feces. When
the observation period was extended to 24 days, phage counts in
excess of 1010 pfu/g feces and cell counts around 109 cfu/g feces were
simultaneously measured in the fecal samples (Fig. 7). Again, mice didFig. 7. Coexistence of T7 podophage and E. coli strain WG-5 in the feces of ﬁve mono-
colonized mice. The fecal excretion pattern of T7 phage (open diamonds, “–”median in
pfu/g displayed at the right ordinate) and E. coli strain WG-5 (ﬁlled circles, “–” median
in cfu/g displayed at the left ordinate) was followed in the mice over 24 days (abscissa).not show changes in appearance, behavior or food intake during the
observation period. In these mice bacteria were only detected in the
cecum and the colon (Fig. 8A). Phages showed high titers in the large
intestine and much lower phage titers were observed in the stomach
and small intestine (Fig. 8B).
Coexisting high phage and bacterial titers were also observed
when germ-free mice were ﬁrst colonized with E. coli strain WG5 and
only 3 days later orally exposed to 106 pfu T7 phage (data not shown).
Then we asked whether the fecal coexistence of E. coli and T7
phage was associated with the in vivo development of phage-resistant
E. coli colonies. Indeed, six out of 30 random fecal E. coli colonies
isolated frommice, which were treated with T7 phage, were resistant
to in vitro infection with the parental podophage.
T7 shows better in vitro growth on late exponential/stationary cells
than T4
WG-5 cells were grown in vitro and infected with T7 phage at 10
different time points representing early, middle, late exponential
phases and transitions to stationary growth phase. The phage titer
observed in the culture supernatant did not change substantially until
the late exponential phase. In the transition to the stationary phase T7
phage titers dropped 10-fold compared to T4 phage which suffered a
1000-fold titer reduction (data not shown). We then infected parallel
cultures of WG-5 cells with T7 or T4 phage at an OD of 0.8, 1.0 and 1.2,
respectively. At these late time points of the bacterial growth phase,
the addition of T4 phage did not decrease the OD of the infected
bacterial culture. In contrast, infection of parallel cultures with T7Fig. 8. Segmental distribution of WG-5 cells (A) and T7 phage (B) across the intestine of
ﬁve mono-colonized mice. The gut segments are indicated by their anatomical location
below the abscissa (for details see legend of Fig. 1). The box displays the distribution of
the titers (the horizontal line in the box gives the median; dotted line is the mean titer).
When only one out of the ﬁvemice showed a cell titer, the value is displayed as a dotted
horizontal line.
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addition, late exponential T7-infected cells yielded at least 100-fold
higher phage titers than T4-infected cells.
Discussion
Oral application of T4-like phages to conventional mice, germ-free
mice and axenic mice mono-colonized with three different E. coli
strains did not induce adverse effects conﬁrming earlier animal
(Chibani-Chennouﬁ et al., 2004b) and human safety studies (Bruttin
and Brüssow, 2005). In patients with E. coli diarrhea, two different
populations of E. coli cells can be distinguished in the gut. On one side
are the pathogenic EPEC and ETEC strains that transiently colonize the
small intestine with high titers (Gorbach et al., 1971; Stintzig and
Möllby, 1982; this might, however, not be the case for Salmonella
infections potentially leading to threshold consequences for phage
therapy approaches (Zuber et al., 2008)). On the other side are the
commensal E. coli strains that colonize the large intestine with small
numbers. Pathogen-speciﬁc T4 phages can be isolated when using
pathogenic E. coli strains for phage isolation and propagation (Chibani-
Chennouﬁ et al., 2004a). However, thesephages turned out to be rather
strain-speciﬁc leading to coverage problems.When isolatingphages on
non-pathogenic indicator cells like K-12 lacking the O side chain of the
LPS antigen, one can obtain T4 phages with broader host range
(Chibani-Chennouﬁ et al., 2004a). In vitro these T4 phages attack both
pathogenic and non-pathogenic E. coli strains (Chibani-Chennouﬁ et
al., 2004b). The commensal E. coli population makes up only a tiny
fraction of the human gut ﬂora. It is unlikely that their reduction by
species-speciﬁc phageswould lead to a health problem. The situation is
very different from the effect of broad spectrum antibiotics given to
patients, which wipe out the very diverse gut ﬂora favoring
colonization with Clostridium difﬁcile leading to serious health
consequences. However, antibiotics are generally not prescribed
against E. coli diarrhea (Djie-Maletz et al., 2008). Children are treated
with oral and if needed intravenous rehydration solution, eliminating
the concern for this collateral damage. Onemight also consider another
type of collateral damage in which a phage is used against target
species A and the gut is also home for a target species B, which is also
sensitive to this phage. The phage might amplify on species A (to high
densities if A is common, e.g. ETEC infection) and wipe out species B
(for example another commensal enterobacterium) even if B is rare
andwould not sustain phage growth by itself. However, during in vitro
tests we have observed only few T4 phages that crossed species
barriers (Zuber et al., 2008) and some reported cross-infections (e.g.
between E. coli and Shigella, (Sulakvelidze et al., 2001)) are less
spectacular than the distinct genus names suggest. Shigella qualiﬁes at
best as a subspecies of E. coli.
However, for phage therapy purpose, oral phage must not only be
safe, it must also demonstrate in vivo lytic activity. In conventional
laboratory mice, which lacked E. coli in their intestine, T4 phage was
not ampliﬁed in vivo and fecal bacterial counts were not reduced by
oral T4 phage (Denou et al., 2009) in accordance with previous
observations (Kasman, 2005). When conventional mice were fed with
E. coli strain K-12, orally applied T4 phage showed some in vivo
replication in the small intestine (Denou et al., 2009). Here we
demonstrate again transient in vivo replication of oral T4 phages (50-
to 300-fold gut titer increase over controls) in axenic mice mono-
colonized with two different E. coli strains.
What might be the reasons for this relatively restricted in vivo
replication potential of T4 phages in mono-colonizedmice? Threshold
phenomena have been discussed in the mathematically-oriented
phage literature (Kasman et al., 2002). However, this is an unlikely
argument: in mono-colonized mice the bacterial counts in the large
intestine were much higher than the critical density of 104 colonies
per ml below which T4 phage does not replicate in vitro (Wiggins and
Alexander, 1985).Water is re-adsorbed from the gut content in the colon and wet
pellets are formed. With the decreasing water content, the spread of
phage to the next target cell becomes diffusion limited. A further factor
which could decrease phage infection is the location of the bacterial
cells within the mucus layer. Mucus is a logical place for colonic
bacteria since it represents a food basis for them (Wadolkowski et al.,
1988). Commensal bacteria in the colon might thus be physically
protected against phage infection. Comparable situations of a spatial
refuge for phage-sensitive bacteria have been described for starter
bacteria enmeshed in the semisolid curd of the coagulatingmilk during
cheese production (Bruttin et al., 1997).
There might also be barriers to phage infection imposed by the
physiological state of the target bacterium. Previous studies reported
metabolically inactive E. coli cells in the gut lumen, while metabol-
ically active E. coli cells were found inmicrocolonies within the mucus
layer of the colon (Krogfelt et al., 1993; Poulsen et al., 1995). In the
laboratory many phages need actively replicating bacterial hosts for
their multiplication: in vitro the T4 phage growth depended heavily
on the synthetic capacity of the host translation machinery (Hadas et
al., 1997). Bacterial commensals in the colon might not replicate at
sufﬁcient speed to represent appropriate target cells for T4 phage
ampliﬁcation. We estimated that under steady state conditions, E. coli
experienced in the colon approximately ﬁve rounds of replication
during a day to replace the fecal bacterial loss compared with a much
faster growth rate (20 min generation time) for E. coli in the
laboratory.
The conclusion that E. coli in the large intestine of mice is not a
target for oral phage cannot be generalized to other classes of
coliphages. T7 podophage replicated to high titers on E. coli colonizing
the large intestine. This strikingly distinct in vivo behavior of T7 and
T4 phages might have an in vitro correlate. T7 phage can lyse E. coli
strains that are in late exponential in vitro growth phase, which T4 is
unable to do (I. Molineux, pers. communication). These observations
concur with reports that T7 unlike T4 can grow in starved cells
(Schrader et al., 1997). The clearly distinct in vitro replication
potential of T4 and T7 phages might thus at least partially explain
the ability of T7 to multiply on intestinal E. coli cells.
We observed high intestinal phage T7 and high E. coli titers over
the duration of the experiment (3weeks). The observation of an about
30-fold higher phage than cell titer in the colon indicated that a
substantial percentage of the colon-colonizing E. coli cells were
infected at any moment and producing T7 phages. The coexistence of
phage and its bacterial target suggests in the mouse gut a pool of
uninfected, but phage-susceptible cells. We postulate that these cells
are physically or physiologically protected from phage infection. This
pool feeds susceptible bacteria into a physical compartment or a
physiological state in the gut where they become infected and
produce progeny phages. Phage-resistant fecal E. coli cells were also
observed and represented a ﬁfth of the intestinal cells. This
percentage is very different from the chemostat experiments where
over 99% of the cells are phage-resistant (Bohannan and Lenski, 2000;
Mizoguchi et al., 2003). The observation of 80% phage-sensitive cells
supports the refuge idea as explanation (Schrag and Mittler, 1996)
while the 1% of phage-sensitive cells in the chemostat experiments is
better explained by a co-evolution of the phages with their hosts.
On the basis of the experiments with mono-colonized mice, one
might deduce that an aggressively replicating phage such as T7 could
prove to be more efﬁcacious than T4 at treating diarrhea. However,
preliminary experiments in ﬁve T7-treated mice, which were mono-
colonized with WG-5, showed a congestion of a conﬁned segment of
the small intestine in three mice. This observation could indicate an
adverse reaction against the high level phage replication and the
concomitant release of bacterial lysis products over a three week
observation period. However, this interpretation should be seen with
caution. The location of the phage replication is in the colon, which
appeared macroscopically normal, while no phage replication
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Furthermore, we lack dissection data from WG-5 colonized control
animals to clearly associate the observed congestion with oral phage
exposure. Germ-free animals are a delicate experimental model,
where the gutmorphology responds dramatically to colonizationwith
microbes and many other frequently unidentiﬁed factors.
Beyond these considerations for phage therapy, the present study
highlights another biological message. E. coli and T4 are one of the
best-characterized interacting biological systems (Karam, 1994).
However, already at the next level of biological complexity, when
T4 and E. coli are studied in their natural ecological setting (the gut of
mammals), data are scarce and in vivo effects cannot be predicted
from the well-investigated in vitro effects (Weld et al., 2004). It might
be time to break with the reductionist principle and investigate
microbe–microbe interactions in complex systems using classics of
microbiology like E. coli and its phages as research tools in these un-
chartered areas.
Materials and methods
Phages and cells
T4-like phages RB49 and RB69 were received from E. Kutter
(Olympia College, Wa, USA) and T7 phage was received from M. de
Paepe (INSERM, Paris, France) (De Paepe and Taddei, 2006). We
screened our T4 phage collection for an isolate growing on E. coli
Nissle strain and we identiﬁed the T4-like phage ED6. The E. coli strain
K-12 derivative K803 was received from E. Kutter (Olympia College,
WA, USA), E. coli strain WG5 was received from J. Jofre (Barcelona
Univ. Spain) and E. coli strain Nissle was isolated from the commercial
Mutaﬂor product (Ardeypharm, Germany). Phages were propagated
on the speciﬁed E. coli strain inoculated into LB broth. For aerobic
growth the culture was agitated at 150 strokes per min, for anaerobic
growth the culture was maintained in an anaerobic jar at 37 °C. The
lysate was cleared by centrifugation and passed through a 0.22 μm
Millipore ﬁlter. The T4 phages were then collected by ultracentrifu-
gation (35,000 ×g for 25 min) and suspended in Vittel mineral water
(Nestlé) to the indicated concentration.
Animal experiments
Adult axenic C3H mice were separated into insulators. Animals
were held under sterile conditions in a Makrolon type 2 cages
maintained in a positive pressure isolator of the animal house. Mice
were fed with sterilized 03-40 chow, drinking water consisted of
sterilized Vittel mineral water with the indicated amount of ﬁlter-
sterilized phage preparation. The mineral water was changed every
two days. The colonization of mice with the indicated E. coli strain was
by intragastric force-feeding (50 μl of a suspension containing109 cfu/
ml). Daily fecal samples were investigated for E. coli titer by colony
counts on LB agar plates. Feces were sampled several times a day
directly from the hand-held animal into a sterile tube by gently
pressing the abdomen of the animals to avoid contamination of the
stool with bedding material or dripping from the water bottles. Fecal
phage titers were determined by the double-layer agar plaque assay
on LB agar. At the end of the experiment mice were sacriﬁced and
standard gross anatomical examination was conducted. At the
speciﬁed time points mice were anaesthetized with isoﬂurane and
killed by bleeding. A blood sample was collected into a heparin tube.
Liver and spleen were dissected as well as the stomach, duodenum,
jejunum (2 segments), ileum (3 segments), cecum, and colon (2
segments). The stomach, cecum and colon contents were extracted
and the small intestine content was recovered by washing with a
syringe. After extraction and washing the mucosa layer was collected
from all gut segments (except the cecum) by scraping. E. coli and the
orally applied phages were counted by colony and plaque assay,respectively. The food intake, mobility, change in behavior and
physical appearance of the mice were noted by the workers in the
animal house. The gross anatomy of the gut and other vital internal
organs was noted during the dissection of the mice.
Microscopy
The gut samples were ﬁxed by incubation in 2.5% glutaraldehyde
in 0.1 M sodium cacodylate buffer pH 7.0 containing 0.04% ruthenium
red and incubated for 16 h at 4 °C. The samples were washed three
times in this buffer followed by an incubation in 2% osmium tetroxide
in the same buffer for 2 h at room temperature. The samples were
washed before dehydration in a series of solutions of increasing
ethanol concentration from 50% to 100%. The samples were then
embedded by three successive 16 h incubations at 4 °C in Spurr 50% in
ethanol, Spurr 75% in ethanol and ﬁnally Spurr 100%. This was then
polymerized for 48 h at 70 °C and semi-thin and ultra-thin sections
were cut with a Reichert OMU2 ultra-microtome. Semi-thin sections
were stained with a solution of 0.5% Toluidine Blue in 1% Borax in
distilled water before examination in bright ﬁeld light microscopy
(Zeiss Axioplan II, magniﬁcation 400×). Ultra-thin sections (thickness,
70 nm) were examined in transmission electron microscopy (TEM)
after staining in uranyl acetate/lead citrate (Philips CM12, 80 kV,
magniﬁcation 128,000×).
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